Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model.
Anti-Inflammatory Agents
/ pharmacology
Biological Products
/ pharmacology
Cannabinoids
/ pharmacology
Cells, Cultured
Cytokine Release Syndrome
/ drug therapy
Cytokines
/ metabolism
Dose-Response Relationship, Drug
Dronabinol
/ pharmacology
Humans
Inflammation Mediators
/ metabolism
Lipopolysaccharides
/ immunology
Sepsis
/ complications
cannabidiol
cannabinoids
inflammation
pro-inflammatory cytokines
sepsis
tetrahydrocannabinol
Journal
European cytokine network
ISSN: 1952-4005
Titre abrégé: Eur Cytokine Netw
Pays: France
ID NLM: 9100879
Informations de publication
Date de publication:
01 Jun 2020
01 Jun 2020
Historique:
entrez:
16
9
2020
pubmed:
17
9
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
Natural cannabinoids may have beneficial effects on various tissues and functions including a positive influence on the immune system and the inflammatory process. The purpose of this study was to investigate the effects of natural cannabinoids on the production of pro-inflammatory cytokines by lipopolysaccharide (LPS)-stimulated whole human blood cells. Levels of the pro-inflammatory cytokines interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were measured before and after exposure of LPS-stimulated whole blood to different concentrations of Cannabidiol (CBD) or a combination of CBD and Tetrahydrocannabinol (THC) extract. LPS stimulated the production of the pro-inflammatory cytokines. Exposure to both CBD and CBD/THC extracts significantly suppressed cytokine production in a dose-dependent manner. Exposure to cannabinoid concentrations of 50 μg/ml or 100 μg/ml resulted in a near-complete inhibition of cytokine production. This study demonstrates that natural cannabinoids significantly suppress pro-inflammatory cytokine production in LPS-stimulated whole blood in a dose-dependent manner. The use of human whole blood, rather than isolated specific cells or tissues, may closely mimic an in vivo sepsis environment. These findings highlight the role that natural cannabinoids may play in suppressing inflammation and call for additional studies of their use as possible novel therapeutic agents for acute and chronic inflammation.
Identifiants
pubmed: 32933892
pii: ecn.2020.0445
doi: 10.1684/ecn.2020.0445
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Biological Products
0
Cannabinoids
0
Cytokines
0
Inflammation Mediators
0
Lipopolysaccharides
0
Dronabinol
7J8897W37S
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM